MoonLake Immunotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $101 | $0 |
Gross Profit | -742 | -378 | 50 | -32 |
EBITDA | -53,177 | -40,010 | -45,053 | -43,079 |
EBIT | -53,919 | -40,388 | -46,354 | -43,112 |
Net Income | -55,220 | -40,253 | -45,604 | -35,390 |
Net Change In Cash | 0 | 0 | 101 | 0 |
Free Cash Flow | -54,530 | -38,175 | -48,649 | -25,407 |
Cash | 306,681 | 271,566 | 180,426 | 375,656 |
Basic Shares | 63,282 | 63,233 | 63,069 | 62,896 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -1,384 | -13 | -12 |
EBITDA | -119,577 | -54,109 | -65,049 |
EBIT | -120,962 | -54,123 | -65,061 |
Net Income | -118,935 | -36,007 | -64,506 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | 31,458 | ||
Free Cash Flow | -117,106 | -43,062 | -55,909 |
Cash | 180,426 | 451,169 | 39,505 |
Basic Shares | 62,870 | 49,122 | 29,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.87 |
2025-03-31 | -$0.63 |
2024-12-31 | -$0.72 |
